Haloperidol induces Fos expression in the globus pallidus and substantia nigra of cynomolgus monkeys

Brain Research

Volumn 835, Issue 2, 1999, Pages 154-161

  Wirtshafter, David ^a   Asin, Karen E ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

c fos; Dopamine; Immediate early genes; Neuroleptic; Primate; Subthalamic nucleus

Indexed keywords

CHOLINE ACETYLTRANSFERASE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; GLOBUS PALLIDUS; IMMEDIATE EARLY GENE; INTRAMUSCULAR DRUG ADMINISTRATION; MONKEY; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

ANIMALS; DOPAMINE ANTAGONISTS; GLOBUS PALLIDUS; HALOPERIDOL; MACACA FASCICULARIS; NERVE TISSUE PROTEINS; PROTO-ONCOGENE PROTEINS C-FOS; SUBSTANTIA NIGRA;

EID: 0033600507     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01550-4     Document Type: Article

References (62)

1. Albin R.L., Young A.B., Penny J.B. The functional anatomy of basal ganglia disorders. TINS. 12:1989;366-375.
2. Alexander G.E., Crutcher M.D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. TINS. 13:1989;266-271.
3. Arbuthnott G., MacLeod N., Ryman A. The effects of dopamine loss on the output from basal ganglia in the rat. J. Physiology. 358:1984;43.
4. Asin K.E., Wirtshafter D., Nikkel A. Amphetamine induces Fos-like immunoreactivity in the striatum of primates. Brain Res. 719:1996;138-142.
5. B.D. Bennett, J.P. Bolam, Localization of calcium binding proteins in the neostriatum, in: G. Percheron, J.S. McKenzie, J. Feger (Eds.), The Basal Ganglia IV, Plenum, New York, 1994, pp. 21-34.
6. Bouthenet M.L., Martres M.P., Sales N., Schwartz J.C. A detailed mapping of dopamine D-2 receptors in rat central nervous system by autoradiography with [125I]iodosulpride. Neuroscience. 20:1987;117-155.
7. Brotchie J.M., Mitchell I.J., Sambrook M.A., Crossman A.R. Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate. Mov. Disord. 6:1997;133-138.
8. Burbaud P., Gross C., Benazzouz A., Coussemacq M., Bioulac B. Reduction of apomorphine-induced rotational behavior by subthalamic lesion in 6-OHDA lesioned rats is associated with a normalization of firing rate and discharge pattern of pars reticulata neurons. Exp. Brain Res. 105:1995;48-58.
9. Chevalier G., Deniau J.M. Disinhibition as a basic process in the expression of striatal functions. TINS. 13:1990;277-285.
10. Chiodo L.A. Dopamine-containing neurons in the mammalian central nervous system: electrophysiology and pharmacology. Neurosci. Biobehav. Rev. 12:1988;49-91.
11. Cole D.G., Di Figlia M. Reserpine increases Fos activity in the rat basal ganglia via a quinpirole sensitive mechanism. Neuroscience. 60:1994;115-123.
12. Cooper A.J., Mitchell I.J. Fos immunopositive neurons in the subthalamic nucleus following reversal of parkinsonian symptoms by antagonism of excitatory amino acid transmission in the entopeduncular nucleus of the monoamine depleted rat. Neurosci. Lett. 201:1995;251-254.
13. Deniau J.M., Kitai S.T., Donoghue J.P., Grofova I. Neuronal interactions in the substantia nigra pars reticulata through axon collaterals of projection neurons. Exp. Brain Res. 47:1982;105-113.
14. Dragunow M., Faull R.L.M. The use of c-fos as a metabolic marker in neuronal pathway tracing. J. Neurosci. Meth. 29:1989;261-265.
15. Everitt B.J., Sirkia T.E., Roberts A.C., Jones G.H., Robbins T.W. Distribution and some projections of cholinergic neurons in the brain of the common marmoset Callithrix jacchus. J. Comp. Neurol. 271:1988;533-558.
16. J. Feger, O.K. Hassani, M. Mouroux, The relationships between subthalamic nucleus, globus pallidus and thalamic parafascicular nucleus, in: C. Ohye, M. Kimura, J.S. McKenzie (Eds.), The Basal Ganglia V, Plenum, New York, 1996, pp. 51-58.
17. J. Feger, P. Robledo, N. Renwart, The subthalamic nucleus: new data, new questions, in: G. Bernadi (Ed.) The Basal Ganglia, III, Plenum, New York, 1994, pp. 99-109.
18. Fenelton V.S., Poulain D.A., Theodosis D.T. Oxytocin neuron activation and Fos expression: a quantitative immunocytochemical analysis of the effect of lactation, parturition, osmotic and cardiovascular stimulation. Neuroscience. 53:1993;777-789.
19. Ficalora A.S., Mize R.R. The neurons of the substantia nigra and zona incerta which project to the cat superior colliculus are GABA immunoreactive: a double-label study using GABA immunocytochemistry and lectin retrograde transport. Neuroscience. 29:1989;567-581.
20. M. Filion, L. Tremblay, V. Chockkan, Complementarity of the two pallidal segments in the primate. in: G. Bernadi (Ed.), The Basal Ganglia III, Plenum, New York, 1993, pp. 73-79.
21. Fritschy J.M., Frondoza C.G., Grzanna R. Differential effects of reserpine on brainstem catecholaminergic neurons revealed by Fos protein immunohistochemistry. Brain Res. 562:1991;48-56.
22. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization. J. Neural. Transm. Suppl. 36:1992;43-59.
23. Harrison M.B., Wiley R.G., Wooten G.F. Changes in D2 but not D1 receptor binding following a selective lesion of striatopallidal neurons. Brain Res. 590:1990;305-310.
24. Hassani O.K., Mouroux M., Feger J. Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus. Neuroscience. 72:1996;105-115.
25. Hughes P., Dragunow M. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol. Rev. 47:1995;133-178.
26. Jimenez-Castellanos J., Graybiel A.M. Subdivisions of the primate substantia nigra pars compacta detected by acetycholinesterase histochemistry. Brain Res. 437:1987;349-354.
27. Kaatz K.W., Albin R.L. Intrastriatal and intrasubthalamic stimulation of metabotropic glutamate receptors: a behavioral and Fos immunohistochemical study. Neuroscience. 66:1995;55-65.
28. Kelland M.D., Soltis R.P., Anderson L.A., Bergstrom D.A., Walters J.R. In vivo characterization of two cell types in the rat globus pallidus which have opposite responses to dopamine receptor stimulation: comparison of electrophysiological properties and responses to apomorphine, dizcilpine and ketamine anesthesia. Synapse. 20:1995;338-350.
29. King S.M., Shehab S., Dean P., Redgrave P. Differential expression of fos like immunoreactivity in the descending projections of superior colliculus after electrical stimulation in the rat. Behav. Brain Res. 78:1996;131-145.
30. Krack P., Pollack P., Limousin P., Hoffmann D., Benazzouz A., Le Bas J.F., Koudsie A., Benabid A.L. Opposite motor effects of pallidal stimulation in Parkinson's disease. Ann. Neurol. 43:1998;180-192.
31. Le Moine C., Bloch B. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNA's in distinct neuronal populations of the dorsal and ventral striatum. J. Comp. Neurol. 355:1995;418-426.
32. Lee H.J., Rye D.B., Hallanger A.E., Levey A.I., Wainer B.H. Cholinergic vs. noncholinergic efferents from the mesopontine tegmentum to the extrapyramidal motor system nuclei. J. Comp. Neurol. 275:1988;469-492.
33. A.M. Loranzo, A.E. Lang, W.D. Hutchison, J.O. Dostrovsky, Microelectrode recording-giuded posteroventral pallidotomy in patients with Parkinson's disease, in: J.A. Obeso, M.R. DeLong, C. Ohye, C.D. Marsden (Eds.), The Basal Ganglia and New Surgical Approached for Parkinson's Disease, Lippincott-Raven, Philadelphia, 1997, pp. 167-174.
34. Mesulam M.M., Mufson E.J., Levey A.I., Wainer B.H. Atlas of cholinergic neurons in the forebrain and upper brainstem of the macaque based on monoclonal choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry. Neuroscience. 12:1984;669-686.
35. F.A. Mettler, Anatomy of the basal ganglia, in: P.J. Vinken, G.W. Bruyn (Eds.), Diseases of the Basal Ganglia. Elsevier, New York, 1975, pp. 1-55.
36. W.C. Miller, M.R. DeLong, Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate mptp model of parkinsonism, in: M.B. Carpenter, A. Jayaraman (Eds.), The Basal Ganglia II, Plenum, New York, 1987, pp. 415-427.
37. Murer G.M., Riquelme L.A., Tseng K.Y., Cristal A., Santos J., Pazo J.H. D1-D2 dopamine interaction: an in vivo single unit electrophysiological study. Neuro Report. 8:1997;783-787.
38. Olds M.E. Amphetamine-induced increase in motor activity is correlated with higher firing rates of non-dopaminergic neurons in substantia nigra and ventral tegmental area. Neuroscience. 24:1988;477-490.
39. Parent A. Extrinsic connections of the basal ganglia. TINS. 13:1990;254-258.
40. Parent A., Mackey A., DeBellefeuille L. The subcortical afferents to caudate nucleus and putamen in primate. A fluorescence retrograde double labeling study. Neuroscience. 10:1983;1137-1150.
41. Parthasarathy H.B., Graybiel A.M. Cortically driven immediate-early gene expression reflects modular influence of sensorimotor cortex on identified striatal neurons in the squirrel monkey. J. Neurosci. 17:1997;2477-2491.
42. Patel N., Hitzemann B., Hitzemann R. Genetics, haloperidol, and the Fos response in the basal ganglia: a comparison of the C57BL/6J and DBA/2J inbred mouse strains. Neuropsychopharmacology. 18:1998;480-491.
43. B. Quinn, A.M. Graybiel, Myeloarchitectonics of the primate caudate-putamen, in: G. Percheron, J.S. McKenzie, J. Feger (Eds.), The Basal Ganglia IV, Plenum, New York, 1994, pp. 35-41.
44. Rajakumar N., Elisevich K., Flumerfelt B.A. Parvalbumin-containing GABAergic neurons in the basal ganglia output system of the rat. J. Comp. Neurol. 350:1994;324-336.
45. Ruskin D.N., Marshall J.F. D1 dopamine receptors influence Fos immunoreactivity in the globus pallidus and subthalamic nucleus of intact and nigrostriatal-lesioned rats. Brain Res. 703:1995;156-164.
46. Ruskin D.N., Marshall J.F. The dopaminergic induction of Fos immunoreactivity in identified populations of globus pallidus neurons. Soc. Neurosci. Abstr. 22:1996;2027.
47. Sagar S.M., Sharp F.R., Curan T. Expression of c-fos protein in brain: Metabolic mapping at the cellular level. Science. 240:1988;1328-1331.
48. J. Scheel-Kruger, G. Magelund, M.C. Olianas, Role of GABA in the striatal output system: Globus pallidus, nucleus entopopeduncularis, substantia nigra and nucleus subthalamicus. in: G. Di Chiara, G.L. Gessa (Eds.), GABA and the Basal Ganglia, Raven Press, New York, 1981, pp. 165-186.
49. Sheng M., Greenberg M.E. The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron. 4:1990;477-485.
50. Smith Y., Parent A. Distribution of acetylcholinesterase-containing neurons in the basal forebrain and upper brainstem of the squirrel monkey (Saimiri sciureus). Brain Res. Bull. 12:1984;95-104.
51. Vargo J.M., Marshall J.F. Reduced eticlopride-induced Fos expression in caudate-putamen and globus pallidus after unilateral frontal cortex injury: relation to neglect. Neuroscience. 76:1997;1083-1095.
52. Vitek J.L., Bsksy R.A.E. The role of pallidotomy in Parkinson's disease and dystonia. Curr. Opin. Neurol. 10:1997;332-339.
53. Walters J.R., Bergstrom D.A., Ruskin D.N., Allers S., Rawji S.S., Twery M.J., Kriess D.S. Relative properties of spike trains in the substantia nigra pars reticulata (SNpr) and subthalamic nucleus (STN) in an animal model of Parkinson's disease. Soc. Neurosci. Abstr. 23:1997;192.
54. Wan X.S.T., Liang F., Moret V., Wiesendanger M., Rouiller E.M. Mapping of the motor pathways in rats: c-fos induction by intracortical microstimulation of the motor cortex correlated with efferent connectivity of the site of cortical stimulation. Neuroscience. 49:1992;749-761.
55. Waszczak B.L., Lee E.K., Tamminga C.A., Walters J.R. Effect of dopamine system activation on substantia nigra pars reticulata output neurons: variable single-unit responses in normal rats and inhibition in 6-hydroxydopamine-lesioned rats. J. Neurosci. 4:1984;2369-2375.
56. Weiser M., Baker H., Wessel T.C., Joh T.H. Axotomy-induced differential gene induction in neurons of the locus coeruleus and substantia nigra. Mol. Brain Res. 17:1993;319-327.
57. Wirtshafter D. Haloperidol and clozapine induce Fos-like immunoreactivity in the primate basal ganglia. Soc. Neurosci. Abstr. 22:1996;1087.
58. Wirtshafter D. Fos expression in the basal ganglia following pharmacological inactivation of the globus pallidus. Soc. Neurosci. Abstr. 23:1997;467.
59. Wirtshafter D., Asin K.E. Dopamine antagonists induce Fos-like-immunoreactivity in the substantia nigra and entopeduncular nucleus of the rat. Brain Res. 670:1995;205-214.
60. Wirtshafter D., Asin K.E., Pitzer M.R. Dopamine agonists and stress produce different patterns of Fos-like immunoreactivity in the lateral habenula. Brain Res. 633:1994;21-26.
61. J. Yelnik, G. Percheron, C. Francois, A. Garnier, Cholinergic neurons of the rat and primate striatum are morphologically different. in: G.W. Arbuthnott, P.C. Emson (Eds.), Progress in Brain Research. Elsevier, New York, 1993, pp. 25-34.
62. Zadow B., Schmidt W.J. Lesions of the entopeduncular nucleus and the subthalamic nucleus reduce dopamine receptor antagonist-induced catalepsy in the rat. Behav. Brain Res. 62:1994;71-79.